Liposomal systems as drug delivery vehicles for dermal and transdermal applications

Arch Dermatol Res. 2011 Nov;303(9):607-21. doi: 10.1007/s00403-011-1166-4. Epub 2011 Jul 30.

Abstract

Enhancement strategies are necessary to improve the dermal/transdermal bioavailability of drugs applied to the skin due to its amazing barrier, the stratum corneum. Strategies to overcome this barrier, thus improving drug release to the skin include the use of penetration enhancers, specific delivery systems, supersaturated solutions and physical methods (iontophoresis, electroporation and ultrasound). Delivery of active agents to the skin by liposomal carriers has improved topical therapy in the field of dermatology. The interest in these carriers is based on their potential to enclose various types of biological materials and to deliver them to diverse cell types. Particularly, in recent years liposomes have been shown to be a promising drug-delivery system to the skin. Their use may produce several-fold higher drug concentrations in the epidermis and dermis and lower systemic concentrations when compared to conventional dosage forms. On the other hand, special characteristic vesicles like ethosomes, transfersomes and niosomes may be potential transdermal delivery systems for ionic molecules and polypeptides.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Dermatology* / methods
  • Dermatology* / trends
  • Dermis* / drug effects
  • Drug Delivery Systems*
  • Electroporation
  • Humans
  • Iontophoresis
  • Liposomes*
  • Peptides / administration & dosage

Substances

  • Liposomes
  • Peptides